Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis.

PloS one - 23 Nov 2009

Matthys Francine, Rigouts Leen, Sizaire Vinciane, Vezhnina Natalia, Lecoq Maryvonne, Golubeva Vera, Portaels Françoise, Van der Stuyft Patrick, Kimerling Michael

Abstract excerpt

Standard short course chemotherapy is recommended by the World Health Organization to control tuberculosis worldwide. However, in settings with high drug resistance, first line standard regimens are linked with high treatment failure. We evaluated treatment outcomes after standardized chemotherap...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antitubercular Agents
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prevalence

Share to Prisoners

Share to Sequence Analysis, DNA

Share to Treatment Outcome

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 19956770
DOI: 10.1371/journal.pone.0007954
PMCID: PMC2776350

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-19956770-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis.PMID 19956770Read ↗

Recent transmission of drug-resistant Mycobacterium tuberculosis in a prison population in southern Brazil.Semantic proximity Read ↗

Treatment outcomes of drug-resistant <i>Mycobacterium tuberculosis</i> infection in Cameroon: a systematic review and meta-analysisSemantic proximity Read ↗

Treatment outcomes of drug-susceptible tuberculosis and its predictors among male prison inmates in Bauchi State, Nigeria, 2014-2018Semantic proximity Read ↗

Evaluation of Mycobacterium tuberculosis associated with treatment failure for intrinsic and efflux pump mediated resistance: a comparative retro perspective cohort studySemantic proximity Read ↗

Tuberculosis cases in a prison in the extreme south of Brazil.Semantic proximity Read ↗

Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology.Semantic proximity Read ↗

New Admissions and Asymptomatic TB Cases fuel TB Epidemic in Prisons, a Cross Sectional Survey in TanzaniaSemantic proximity Read ↗

Reinfection and Mixed Infection Cause Changing <i>Mycobacterium tuberculosis</i> Drug-Resistance PatternsSemantic proximity Read ↗

Drug-Resistant Tuberculosis in Prisons of Latin America and the Caribbean: A Critical Reflection on Structural Challenges and GapsSemantic proximity Read ↗

Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.Semantic proximity Read ↗

Isoniazid monoresistant tuberculosis treatment outcomes in Puducherry, South India - A mixed methods study.Semantic proximity Read ↗

Use of rapid molecular tuberculosis diagnostics across Brazil’s incarcerated populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.